Arbutus Biopharma Corporation ABUS Common stock, shares issued (in shares)
Common stock, shares issued (in shares) at other companies
Other financials
Where this comes from
Reported directly by Arbutus Biopharma Corporation in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arbutus Biopharma Corporation's common stock, shares issued (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arbutus Biopharma Corporation's common stock, shares issued (in shares)?
- Arbutus Biopharma Corporation (ABUS) reported common stock, shares issued (in shares) of $196.95M in Q1 2026.
- How has Arbutus Biopharma Corporation's common stock, shares issued (in shares) changed year-over-year?
- Arbutus Biopharma Corporation's common stock, shares issued (in shares) increased by 2.9% year-over-year, from $191.48M to $196.95M.
- What is the long-term trend for Arbutus Biopharma Corporation's common stock, shares issued (in shares)?
- Over 5 years (2020 to 2025), Arbutus Biopharma Corporation's common stock, shares issued (in shares) has grown at a 16.5% compound annual growth rate (CAGR), from $89.68M to $192.53M.